On July 7, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued its weekly Enforcement Report for July 6 that lists the status of recalls and field corrections for food, drugs, biologics and devices (here). The report covers both domestic and foreign firms.

On July 6, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On July 5, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration ended its increased surveillance procedures for "FDA-regulated products imported from the industrial center Binhai New Area in Tianjin, China, and Xiditou Township of Beichen District in Tianjin, China," CBP said in a CSMS message (here). "FDA has returned to routine surveillance of FDA-regulated products from this region." The FDA increased the surveillance after a major explosion at a Chinese port caused chemical contamination risks for goods from that area (see 1512230069).

On July 1, the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

On June 30 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued its weekly Enforcement Report for June 29 that lists the status of recalls and field corrections for food, drugs, biologics and devices (here). The report covers both domestic and foreign firms.

On June 29 the Food and Drug Administration posted new and revised versions of the following Import Alerts on the detention without physical examination of:

The Food and Drug Administration issued new guidance (here) for manufacturers of food and dietary supplements outlining agency policy on declaring small amounts of certain nutrients and dietary ingredients on nutrition labels. The document clarifies when FDA will use its enforcement discretion in cases in which a conflict may occur between FDA regulations on how to declare certain nutrients and dietary ingredients when present in small amounts.